Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine

Circulation

Volumn 89, Issue 5, 1994, Pages 2176-2182

  Tsao, Philip S ^a   McEvoy, Leslie M ^a   Drexler, Helmut ^a   Butcher, Eugene C ^a   Cooke, John P ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

arginine; atherosclerosis; endothelium derived factors

Indexed keywords

ARGININE; ARGININE DERIVATIVE; CHOLESTEROL; DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDRALAZINE; LOW DENSITY LIPOPROTEIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; MALE; MONOCYTE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THORACIC AORTA;

EID: 0028293434     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.5.2176     Document Type: Article

References (44)

1. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 1986; 314:488-500.
2. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res. 1988;63:903-910.
3. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 1987;327:237-239.
4. Tomita T, Ezaki M, Miwa M, Nakamura K, Inoue Y. Rapid and reversible inhibition by low density lipoprotein of the endothelium-dependent relaxation to hemostatic substances in porcine coronary arteries. Circ Res. 1990;66:18-27.
5. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344: 160-162.
6. Heistad DD, Armstrong MLI, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;43:711-718.
7. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets. Br J Pharmacol. 1987;92:181-187.
8. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
9. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
10. Cooke JP, Tsao P. Cytoprotective effects of nitric oxide. Circulation. 1993;88:2451-2454.
11. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991; 88:4651-4655.
12. Bath PMW, Hassall DG, Gladwin A-M, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254-260.
13. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in amelio-rating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86:279-288.
14. Siegfried MR, Carey C, Ma XL, Lefer AM. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol. 1992;263:H771-H777.
15. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets. Br J Pharmacol. 1987;92:181-187.
16. Stamler JS, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J. N-Acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res. 1989;65:789-795.
17. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
18. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res. 1990:67:1301-1308.
19. Creager MA, Girerd XJ, Gallagher SJ, Coleman S, Dzau VJ, Cooke JP. L-Arginine normalizes endothelial response in the forearm circulation of hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
20. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.
21. Kuo L, Davis MF, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ Res. 1992;70:465-476.
22. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
23. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
24. Bush PA, Gonzalez NE, Griscavage JM, Ignarro LJ. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun. 1992;185:960-966.
25. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
26. McCord JM, Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem. 1968;243:5753-5760.
27. Fong LG, Fong TA, Cooper AD. Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma. J. Biol Chem. 1990;265:11751-11760.
28. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate, I: changes that lead to fatty streak formation. Arteriosclerosis. 1984;4:323-340.
29. Masuda J, Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate, I: fatty streak formation. Arteriosclerosis. 1990;10:178-187.
30. de Gruijter M, Hoogerbrugge N, van Rijn MA, Koster JF, Sluiter W, Jongkind JF. Patients with combined hypercholesterolemia-hypertriglyceridemia show an increased monocyte-endothelial cell adhesion in vitro: triglyceride level as a major determinant. Metabolism. 1991;40:1119-1121.
31. Territo MC, Berliner JA, Almada L, Ramirez R, Fogelman AM. β-Very Low Density Lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Arteriosclerosis. 1989; 9:824. Abstract.
32. Endemann G, Pronzcuk A, Friedman G, Lindsey S, Alderson L, Hayes KC. Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. Am J Pathol. 1989;126:1-6.
33. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Banmshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
34. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz C, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87:5134-5138.
35. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mono-nuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
36. Zeiher AH, Schray-Utz B, Busse R. Nitric oxide modulates monocyte chemoattractant protein 1 in human endothelial cells: implications for the pathogenesis of atherosclerosis. Circulation. 1993;88(suppl I):I-367. Abstract.
37. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res. 1988;63:903-910.
38. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin Invest. 1990;86:228-234.
39. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA. 1987;84:7725-7729.
40. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin Invest. 1993;91:2546-2551.
41. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol. 1986;250:H815-H821.
42. Lehr H-A, Becker M, Marklund SL, Hübner C, Arfors KE, Kohlschütter A, Messmer K. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Thromb. 1992;12:824-829.
43. Mao S, Yates M, Lambert L, Whitten J, McDonald I, Ku G, Mano M. Nitric oxide protects the oxidative modification of low density lipoprotein by macrophages. FASEB J. 1992;6:A1030. Abstract.
44. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 1992;90:1116-1121.